content top

Ten Years Retropsective Study for Management of Macular Edema Treatments in Retinal Vein Occlusion (Part 2 & Synthesis)

Rita Soyeur, Frédéric Hamon, Alexis Pinel, France Contact Details:   Frédéric Hamon Centre Helios Ophthalmologie St Jean de Luz France Cell Phone: +33662046330 Work Phone: +33559518660 Email :...

Read More

10 Years Retrospective Study for Management of Macular Edema Treatments in Retinal Vein Occlusion: Some First Line Treatments Seem Worse Than Others!

ABSTRACT Purpose: Review of patients with bad results after ME treatments in RVO and try to understand if some first line treatment are better -or worse. Material & Methods: Both BRVO and CRVO were included in this retrospective study. (2007-2017). 345 patients included (179 BRVO and 166 CRVO). All patients had complete check-up with VA, Fundus, TO, OCT and Fluorescein angiography (before and after treatment(s)). First line treatment...

Read More

First Results with Noctura 400 Sleep Mask for Chronic Macular Edema Treatment

ABSTRACT Purpose: To evaluate potential efficacy of a Class IIa 12 week medical device with CE certification and ISO13485 in treatment of chronic ME reluctant to pall previous other treatment. Material & Methods: 10 patients included in this study (5 RVO, 1 DR, 1 post RD, 3 post ERM). All patients had multiple previous treatments for chronic ME, included ILM peeling, multiple anti-VEGF IVT, Corticosteroids IVT or subtenon, eyedrops,...

Read More

Macular Edema Management with Multiple IVTs Required: There is No Reason Why ILM Peeling Should Not Be Considered at One Time

Macular Edema Management with Multiple IVTs Required: There is No Reason Why ILM Peeling Should Not Be Considered at One Time ABSTRACT Purpose: A discussion why ILM peeling should be proposed to every patient with a recurrent or chronic Macula Edema. Discussion: All kinds of RVO, BRVO, or DR could be associated to a recurrent or chronic ME. EVRS ME study teached us possibility of very good results with ILM peeling, and efficiency...

Read More

Combined Intravitreal Anti-VEGF & Subtenon Corticosteroids in AMD to Reduce ME Recurrence and Increase Delay Between IVTs: An Update and Some Lessons

Combined Intravitreal Anti-VEGF & Subtenon Corticosteroids in AMD to Reduce ME Recurrence and Increase Delay Between IVTs: An Update and Some Lessons ABSTRACT Purpose: To evaluate with time efficiency of combined treatment using Anti-VEGF & subtenon (or subconjonctival) corticosteroids in ME recurrence in AMD Material & Methods: All kinds of CNV in AMD were included in this retrospective study (classic, minimally classic,...

Read More

Micropulse Laser 577 nm: A Perfect « Second Line » Treatment for ME ?

Purpose: The authors report several tips and tricks increasing efficiency of 577 nm Micropulse Laser (MIP) in treatment of macular oedema recurrence in eyes with previous ILM peeling surgery. Methods: The study is a retrospective clinical study of sub threshold laser treatment as a tissue-sparing laser photocoagulation for ME. Eyes included underwent treatment for ME due different pathologies (Diabetic Retinopathy, branch or central...

Read More

Combined Intravitreal Anti-VEGF & Subtenon Corticosteroids in AMD Reduces ME Recurrence and Increases Delay Between IVTs

Purpose:  To evaluate, with time, efficiency of combined treatment using Anti-VEGF & subtenon corticosteroids in ME recurrence in AMD Material and methods: All kinds of CNV in AMD were included in this retrospective study (classic, minimally classic, occult, PEDs…). Both Ranibizumab and Aflibercept were used and associated with subtenon corticosteroids. Corticosteroid was mostly bethamethasone acetate vs triamcinolone...

Read More

Micropulse Laser for ME: Principles, New Parameters and Results with 577 nm

Poster Frederic Hamon Purpose: The authors report their experience using 577 nm Micropulse Laser (MIP) in treatment of macular edema due to different pathologies. Methods: The study is a retrospective clinical trial evaluation of sub threshold laser treatment as a tissue-sparing laser photocoagulation for ME. 100 eyes underwent treatment for ME due to Diabetic Retinopathy, branch or central retinal vein occlusion, or other causes including...

Read More

Combined Intravitreal Anti-VEGF & Subtenon Corticosteroids in AMD to Reduce ME Recurrence

Purpose:  To evaluate combined treatment of Anti-VEGF & subtenon corticosteroids for recurrent macular edema (ME) associated to choroidal neovascularization (CNV) due to age related macular degeneration (AMD). Material & Methods: Cases of CNV in AMD were included in this retrospective study. All types of CNV could be included (classic, minimally classic, occult, PEDs) Results: This combined therapy seemed to decrease ME...

Read More

New 27 Gauge Microforceps: Efficiency Depends of the Distal Design

The authors present an improvement to the distal design of a 27 gauge microforceps. This leads to better efficiency for macular surgery, even with a very small 27 gauge instrument. It seems to be one of the first steps to create a real possibility of 27 gauge vitreoretinal surgery.

Read More

Hybrid 27 / 25 Gauge Vitrectomy for Macular Surgery with Flow Control

The authors present  an update of hybrid vitrectomy 27/25 gauge, compared to their previous 25/23 gauge surgery for vitreomacular diseases. It compares parameters with flow control, trying to evaluate maximum possibilities of such a 27/25 gauge system. Flow control appears to be a”must have” for developing such...

Read More

Interest of the Use of 25 Gauge Vitrectomy Technique in Diabetic Retinopathy

Jean Pierre Hubschman, Rita Soyeur The transconjonctival vitrectomy system presents some real advantages in cases of diabetic retinopathy. In fact, this new technique without conjunctival opening nor closing is perfectly adapted for most of vitreo-retinal surgical cases in diabetic retinopathy. Now, we have the opportunity to perform less traumatic vitreo-retinal surgery in tractional macular edema and moderate proliferative retinopathy, it...

Read More
content top